First Malaria Treatment Approved for Infants Under 5kg
Pharmaceutical company Novartis announced Swiss regulatory approval Tuesday for Coartem Baby, the first malaria treatment specifically developed for babies and young children weighing less than 5 kilograms. This approval addresses a critical treatment gap …